InflaRx IFRX
NASDAQ IFRX
$2.10 +0.08 (+3.96%)
At close: Aug 21, 2026 · 4:00 PM EDT

InflaRx (IFRX) Sales of Property, Plant and Equipment (2018 - 2025)

InflaRx (IFRX) Sales of Property, Plant and Equipment (2018 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 5.85 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 698,426.11
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 InflaRx 140.30 Mn -43.96 Mn 2.74 Bn 14.98 Mn

Historic Data

Download Data
DateValue
Sep 30, 2025 15.52 Mn
Sep 30, 2025 15.52 Mn
Jun 30, 2025 12.02 Mn
Jun 30, 2025 12.02 Mn
Mar 31, 2025 18.58 Mn
Mar 31, 2025 18.58 Mn
Sep 30, 2024 24.22 Mn
Sep 30, 2024 24.22 Mn
Jun 30, 2024 27.67 Mn
Jun 30, 2024 27.67 Mn
Mar 31, 2024 33.16 Mn
Mar 31, 2024 33.16 Mn
Sep 30, 2023 17.32 Mn
Sep 30, 2023 17.32 Mn
Jun 30, 2023 36.66 Mn
Jun 30, 2023 36.66 Mn
Mar 31, 2023 23.12 Mn
Mar 31, 2023 23.12 Mn
Sep 30, 2022 5.05 Mn
Sep 30, 2022 5.05 Mn